Clinical trials
Carcinoma, Non-Small-Cell Lung trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
624 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 7 |
| 2002 | 5 |
| 2003 | 9 |
| 2004 | 11 |
| 2005 | 20 |
| 2006 | 28 |
| 2007 | 16 |
| 2008 | 18 |
| 2009 | 21 |
| 2010 | 17 |
| 2011 | 15 |
| 2012 | 14 |
| 2013 | 13 |
| 2014 | 25 |
| 2015 | 31 |
| 2016 | 23 |
| 2017 | 36 |
| 2018 | 34 |
| 2019 | 33 |
| 2020 | 26 |
| 2021 | 35 |
| 2022 | 42 |
| 2023 | 31 |
| 2024 | 34 |
| 2025 | 33 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 287 |
| Active, not recruiting | 116 |
| Terminated | 94 |
| Recruiting | 91 |
| Unknown status | 17 |
| Withdrawn | 9 |
| Not yet recruiting | 8 |
| Available | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 46 |
| Novartis Pharmaceuticals | 36 |
| Bristol-Myers Squibb | 35 |
| Pfizer | 31 |
| University Health Network, Toronto | 27 |
| Eli Lilly and Company | 24 |
| Merck Sharp & Dohme LLC | 23 |
| Hoffmann-La Roche | 19 |
| GlaxoSmithKline | 16 |
| Alliance for Clinical Trials in Oncology | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 624 |
| Lung Neoplasms | 162 |
| Neoplasms | 68 |
| Colorectal Neoplasms | 49 |
| Melanoma | 45 |
| Breast Neoplasms | 37 |
| Neoplasm Metastasis | 35 |
| Squamous Cell Carcinoma of Head and Neck | 33 |
| Carcinoma | 26 |
| Ovarian Neoplasms | 26 |
Trials
Showing 1 to 25 of 624. Each trial links to its page on Pharma Observatory.
524 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.